Stay updated on Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and v3.4.2 removed, indicating a minor version update to the page.
    Difference
    0.1%
    Check dated 2026-03-12T01:05:20.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now shows a new revision label (Revision: v3.4.2) and the funding-notice has been removed, which are minor site-wide UI changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T12:08:12.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide funding notice was added at the top of the page. The page revision label was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T06:45:54.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary added and QC-related metadata updated (Last Update Submitted that Met QC Criteria) and Revision: v3.4.0; older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) were removed. These changes affect only UI text and metadata and do not alter the study content.
    Difference
    0.2%
    Check dated 2026-01-28T04:44:34.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page shows a new revision tag 'Revision: v3.3.4' replacing 'Revision: v3.3.3'. No study details or essential content appear to be affected.
    Difference
    0.1%
    Check dated 2026-01-14T03:02:29.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations now lists Cincinnati, Ohio as a study site under the Locations section. The Ohio Locations subsection was removed and the HHS Vulnerability Disclosure link was deleted.
    Difference
    0.2%
    Check dated 2025-12-23T20:34:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial page.